CooperCompanies Announces First Quarter 2026 Results

Core Insights - CooperCompanies reported strong financial results for the fiscal first quarter ended January 31, 2026, with significant revenue growth and improved profitability [1][2][6]. Financial Performance - Total revenue for the first quarter was $1.024 billion, representing a 6% increase year-over-year, with a 3% organic growth [6][7]. - GAAP diluted earnings per share (EPS) increased to $0.66, up 27% from the previous year, while non-GAAP diluted EPS rose to $1.10, a 20% increase [6][41]. - Gross margin remained stable at 68%, while operating margin improved to 21% from 19% in the prior year, driven by operational efficiencies [7][41]. Segment Performance - CooperVision (CVI) revenue was $695.1 million, up 8% year-over-year, with a 3% organic growth [8][43]. - CooperSurgical (CSI) revenue reached $329.0 million, a 3% increase from the previous year, with 2% organic growth [9][43]. Cash Flow and Capital Allocation - The company generated free cash flow of $158.7 million during the quarter, supporting ongoing share repurchases totaling $92.5 million [3][10]. - CooperCompanies aims to generate over $2.2 billion in free cash flow from 2026 to 2028, providing flexibility for growth investments and debt reduction [3]. Guidance and Outlook - The company updated its fiscal year 2026 financial guidance, projecting total revenue between $4.306 billion and $4.346 billion, with organic growth of 4.5% to 5.5% [13]. - Non-GAAP diluted EPS guidance for fiscal 2026 is set between $4.58 and $4.66, with free cash flow expected to be between $600 million and $625 million [13].